Big Pharma markets left on a ‘patent cliff’-h...

As Americans prepare to vote in the November 3 midterm elections, the FT’s chief economics commentator Martin Wolf asks what the result will mean for Donald Trump, the future of US democracy and America's place in the world. In the third of a six-part series, Martin speaks to pol ...  Show more

Alphabet’s share price fell just over 12 percent on Thursday, and UK startup Nscale is banking on a troubled US data centre project to underpin its planned $35bn IPO. Plus, we look at what’s next for the ECB now that its president Christine Lagarde announced she’s stepping down.M ...  Show more

India could soon see its largest-ever pharma deal as the 10th biggest pharma company by revenues -- Torrent -- is trying to buy the fourth largest one -- Cipla. But, is the bullet too big to bite for Torrent? Is the funding feasible? Will the compatibility not of portfolio but ...

India's primary market is set to witness back-to-back billion-dollar IPOs, including Hyundai's record-breaking Rs 25,000 crore issue. With heavyweights like Swiggy and Afcons Infrastructure also preparing to go public, investors are closely watching the potential market impact. W ...  Show more

Zee's diverse content and Sony's global muscle promised a Bollywood blockbuster of a merger. But the highly romanticised story takes a dramatic turn! Rumours are swirling that the $10 billion mega-merger might be off. What are the hurdles? And what went wrong in the two years? ...